A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia-Reference-Cited by-同舟云学术

A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia

Published:2004-03 Issue:2 Volume:28 Page:361-369
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Suzuki Takefumi,Uchida Hiroyuki,Watanabe Koichiro,Yagi Gohei,Kashima Haruo

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference39 articles.

1. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV);American Psychiatric Association,1994

2. Practice guideline for the treatment of patients with schizophrenia;American Psychiatric Association;Am. J. Psychiatry,1997

3. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychosis;Baldessarini;Arch. Gen. Psychiatry,1988

4. When symptoms persist: clozapine augmentation strategies;Buckley;Schizophr. Bull.,2001

5. Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness;Chou;J. Clin. Psychopharmacol.,2000

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antipsychotic polypharmacy in adult patients diagnosed with schizophrenia: A retrospective study;Experimental and Therapeutic Medicine;2021-08-27

2. Positive evidence for clinical pharmacist interventions during interdisciplinary rounding at a psychiatric hospital;Scientific Reports;2021-07-01

3. Positive impact of clinical pharmacist interventions on antipsychotic use in patients on excessive polypharmacy evidenced in a retrospective cohort study;Global Psychiatry;2019-08-20

4. Differences in High Dose Antipsychotic Prescriptions in Patients with Schizophrenia in Asian Countries/Areas: Findings from the REAP-AP Study;Psychiatry Investigation;2018-10-25

5. Combination Antipsychotic Therapies;Journal of Clinical Psychopharmacology;2017-10